Literature DB >> 29346499

Repeatability and Agreement of Visual Acuity Using the ETDRS Number Chart, Landolt C Chart, or ETDRS Alphabet Chart in Eyes With or Without Sight-Threatening Diseases.

Voraporn Chaikitmongkol1, Onnisa Nanegrungsunk2, Direk Patikulsila1, Paisan Ruamviboonsuk3, Neil M Bressler4,5.   

Abstract

Importance: The Early Treatment Diabetic Retinopathy Study (ETDRS) alphabet chart is not feasible for measuring best-corrected visual acuity (BCVA) for individuals who are unfamiliar with the Roman alphabet. The ETDRS Landolt C chart is an alternative, but it may not reflect true BCVA among those with confusion between left and right. The ETDRS number chart might overcome these limitations, but little is known regarding its reliability. Objective: To evaluate repeatability and agreement of BCVA using the ETDRS number chart or Landolt C chart compared with ETDRS alphabet charts in healthy and diseased eyes. Design, Setting, and Participants: A cross-sectional study was conducted in Thailand from July 1, 2015, to June 30, 2016, among 154 adult Thai individuals. Those who could read Roman alphabets were classified into the following 4 groups, using 1 eye per participant: group A, which comprised 60 healthy eyes (BCVA, 20/20-20/25); group B, which comprised 40 eyes with age-related cataract, diabetic macular edema, or age-related macular degeneration (BCVA, 20/20-20/40); group C, which comprised 40 eyes with age-related cataract, diabetic macular edema, or age-related macular degeneration (BCVA, 20/50-20/100); and group D, which comprised 14 eyes with age-related cataract, diabetic macular edema, or age-related macular degeneration (BCVA, 20/125-20/200). Interventions: Two standardized 4-m BCVA measurements with 3 different Precision Vision ETDRS charts (PV number, Landolt C, and alphabet), in random sequence, performed 30 minutes apart. Main Outcomes and Measures: Repeatability, agreement, and testing duration of BCVA.
Results: Of 154 Thai participants (82 women and 72 men; mean [SD] age, 52.9 [18.2] years), the ETDRS number chart had strong repeatability coefficients (group A, 0.61 [95% CI, 0.42-0.75]; group B, 0.87 [95% CI, 0.78-0.93]; group C, 0.81 [95% CI, 0.67-0.90]; and group D, 0.81 [95% CI, 0.49-0.94]). Concordance correlation coefficients between the number and alphabet charts were also strong (group A, 0.89 [95% CI, 0.82-0.93]; group B, 0.97 [95% CI, 0.94-0.98]; group C, 0.92 [95% CI, 0.86-0.96]; and group D, 0.96 [95% CI, 0.87-0.99]), while the concordance correlation coefficients between the Landolt C and alphabet charts were lower (group A, 0.72 [95% CI, 0.52-0.83]; group B, 0.83 [95% CI, 0.68-0.91]; group C, 0.79 [95% CI, 0.61-0.89]; and group D, 0.89 [95% CI, 0.66-0.97]). The mean letter score difference between the number and alphabet charts was 1 (95% limits of agreement, -4 to +6) compared with -7 (95% limits of agreement, -18 to +5; P < .001) between the Landolt C and alphabet charts. Conclusions and Relevance: The repeatability coefficients and concordance correlation coefficients suggest that ETDRS number charts are viable for measuring BCVA in clinical practice and trials for individuals who are unfamiliar with the Roman alphabet.

Entities:  

Mesh:

Year:  2018        PMID: 29346499      PMCID: PMC5885907          DOI: 10.1001/jamaophthalmol.2017.6290

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  10 in total

1.  New design principles for visual acuity letter charts.

Authors:  I L Bailey; J E Lovie
Journal:  Am J Optom Physiol Opt       Date:  1976-11

2.  Standardizing the measurement of visual acuity for clinical research studies: Guidelines from the Eye Care Technology Forum.

Authors:  F L Ferris; I Bailey
Journal:  Ophthalmology       Date:  1996-01       Impact factor: 12.079

3.  The early treatment in diabetic retinopathy study chart compared with the tumbling-E and Landolt-C.

Authors:  Maxwell P Treacy; Tara P Hurst; Marcus Conway; Emma S Duignan; Borislav D Dimitrov; Nicholas Brennan; Lorraine Cassidy
Journal:  Ophthalmology       Date:  2015-01-10       Impact factor: 12.079

4.  Assessing visual acuity across five disease types: ETDRS charts are faster with clinical outcome comparable to Landolt Cs.

Authors:  Simone Koenig; Felix Tonagel; Ulrich Schiefer; Michael Bach; Sven P Heinrich
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-28       Impact factor: 3.117

5.  Standardized illumination for visual acuity testing in clinical research.

Authors:  F L Ferris; R D Sperduto
Journal:  Am J Ophthalmol       Date:  1982-07       Impact factor: 5.258

6.  New visual acuity charts for clinical research.

Authors:  F L Ferris; A Kassoff; G H Bresnick; I Bailey
Journal:  Am J Ophthalmol       Date:  1982-07       Impact factor: 5.258

Review 7.  Recommended stardard procedures for the clinical measurement and specification of visual acuity. Report of working group 39. Committee on vision. Assembly of Behavioral and Social Sciences, National Research Council, National Academy of Sciences, Washington, D.C.

Authors: 
Journal:  Adv Ophthalmol       Date:  1980

8.  Visual acuity as measured with Landolt C chart and Early Treatment of Diabetic Retinopathy Study (ETDRS) chart.

Authors:  Hsi-Kung Kuo; Ming-Tse Kuo; Ing-Soo Tiong; Pei-Chang Wu; Yung-Jen Chen; Chih-Hsin Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-07-24       Impact factor: 3.117

9.  Repeatability of an automated Landolt C test, compared with the early treatment of diabetic retinopathy study (ETDRS) chart testing.

Authors:  Paisan Ruamviboonsuk; Montip Tiensuwan; Catleya Kunawut; Patcharapim Masayaanon
Journal:  Am J Ophthalmol       Date:  2003-10       Impact factor: 5.258

10.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.

Authors: 
Journal:  JAMA       Date:  2013-11-27       Impact factor: 56.272

  10 in total
  4 in total

1.  Validation of the New York University Langone Eye Test Application, a Smartphone-Based Visual Acuity Test.

Authors:  Mina Iskander; Galen Hu; Shefali Sood; Noah Heilenbach; Victor Sanchez; Titilola Ogunsola; Dinah Chen; Ceyhun Elgin; Vipul Patel; Andrew Wronka; Lama A Al-Aswad
Journal:  Ophthalmol Sci       Date:  2022-06-15

2.  Portable rotating grating stimulation for anisometropic amblyopia with 6 months training.

Authors:  Wen-Hsiu Yeh; Li-Ju Lai; Da-Wei Chang; Wei-Sin Lin; Guan-Ming Lin; Fu-Zen Shaw
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

3.  Therapeutic Effect of Abelmoschus manihot on Type 2 Diabetic Nonproliferative Retinopathy and the Involvement of VEGF.

Authors:  Yue Zhao; Xu Yu; Yan Lou; Xinyi Sun; Boyu Zhu; Weilong Xu; Lei Zhou; Hao Wu; Qingzi Jin; Heng Wang; Jianjiang Shen; Jiangyi Yu; Xiaofei An
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-30       Impact factor: 2.629

4.  A reassessment and comparison of the Landolt C and tumbling E charts in managing amblyopia.

Authors:  Yu-Hung Lai; Horng-Jiun Wu; Shun-Jen Chang
Journal:  Sci Rep       Date:  2021-09-14       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.